MON 21 SEPMorning2:42 PM

Back to the brief

BIZCNBC

Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production

Photo: CNBC

Eli Lilly is trying to catch up in the GLP-1 pill market to Novo, which got a head start in the space.

Read the original report

Opens CNBC in a new tab